from Industrial Alliance Securities issued a price target of $3.25 for CCIF on 2026-08-20 18:51:10.The adjusted price target was set to $3.25.At the time of the announcement, CCIF was trading at $2.74.The overall price target consensus is at $3.75 with high price of $3.75, low price of $3.75, and median price is at $3.75.CCIF currently...
DouYu International Holdings Limited (DOYU) confirmed earnings release on August 20, 2026, Before the market for...
Lyra Therapeutics, Inc. (LYRA) confirmed earnings release on August 20, 2026, for the quarter ending June...
Yiren Digital Ltd. (YRD) confirmed earnings release on August 20, 2026, Before the market for the...
Kandi Technologies Group, Inc. (KNDI) confirmed earnings release on August 20, 2026, Before the market for...
from Industrial Alliance Securities issued a price target of $3.25 for CCIF on 2026-08-20 18:51:10.The adjusted price target was set to $3.25.At the time of the announcement, CCIF was trading...
Marie Thibault from BTIG issued a price target of $2.00 for HYPR on 2026-08-20 13:07:00.The adjusted price target was set to $2.00.At the time of the announcement, HYPR was trading...
from Northland Securities issued a price target of $32.00 for FTK on 2026-08-20 12:59:52.The adjusted price target was set to $32.00.At the time of the announcement, FTK was trading at...
from Cantor Fitzgerald issued a price target of $3.00 for MIST on 2026-08-20 10:09:19.The adjusted price target was set to $3.00.At the time of the announcement, MIST was trading at...
from BTIG issued a price target of $32.00 for LWAY on 2026-08-20 09:47:55.The adjusted price target was set to $32.00.At the time of the announcement, LWAY was trading at $25.04.The...
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
